Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$69.26BHealthcare Market cap, Sector
Veracyte
VCYT$4.28BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 61 VCYT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS6wins
1winsVCYT
84B
D46
87A
D57
92A
C61
66C
C68
75B
D46
91A
D47
95A
D52
Side-by-side metrics
| Metric | JSLL.NS | VCYT |
|---|---|---|
| Market cap | Winner: $69.26B | $4.28B |
| P/E (TTM) | Winner: 33.3x | 34.8x |
| EV/EBIT | Winner: 24.1x | 38.4x |
| ROIC (TTM) | Winner: 39.15% | 4.73% |
| Gross margin | Winner: 88.58% | 71.31% |
| Net margin | Winner: 27.68% | 16.25% |
| Revenue CAGR 5y | Winner: 57.81% | 23.89% |
| EPS CAGR 5y | 86.67% | - |
| Debt / Equity | 0.3x | 0.0x Winner |
| Dividend yield | - | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Market cap$69.26Bvs $4.28B+94%
- ROIC (TTM)39.15%vs 4.73%+88%
- Revenue CAGR 5y57.81%vs 23.89%+59%
- Net margin27.68%vs 16.25%+41%
VCYT leads on
- Debt / Equity0.0xvs 0.3x+89%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.